-
Dextrose (D-Glucose) for Tumor Immunometabolism
2026-09-21
Use Dextrose (D-glucose) to build controlled nutrient gradients, test hypoxia-driven metabolic competition, and separate tumor-cell energy demand from immune-cell dysfunction. This workflow combines practical media preparation, factorial oxygen–glucose experiments, and troubleshooting guidance for reproducible glucose metabolism research.
-
Omega-3 PUFAs Protect Neonatal Mice from Sevoflurane
2026-09-20
This study identifies impaired glymphatic clearance of phosphorylated tau as a mechanistic link between repeated neonatal sevoflurane exposure and later cognitive and fine motor deficits. Maternal dietary omega-3 polyunsaturated fatty acids preserved AQP4 polarization, improved PDGF-B/PDGFRβ-associated glymphatic transport, and reduced mitochondrial and apoptotic injury in offspring.
-
Vacuolin-1 Workflows for Lysosomal Exocytosis
2026-09-19
Vacuolin-1 enables selective perturbation of lysosomal exocytosis without treating membrane traffic as a single process. This guide connects practical β-hexosaminidase and surface Lamp-1 assays with plasma membrane repair research and disease-oriented cartilage studies.
-
VX-661: F508del CFTR Corrector Workflows
2026-09-19
Build more informative cystic fibrosis research assays with VX-661 by separating CFTR trafficking rescue from acute channel potentiation. This workflow combines controlled correction, surface-expression measurements, functional testing, and calnexin-aware variant analysis for better interpretation of F508del mutation responses.
-
EdU Flow Cytometry Assay Kits (Cy3): Guide
2026-09-18
EdU Flow Cytometry Assay Kits (Cy3) use EdU incorporation and Cy3 click chemistry to quantify DNA synthesis during S phase without harsh DNA denaturation. The K1077 workflow supports cell cycle analysis by flow cytometry, multiplexed marker studies, genotoxicity testing, and pharmacodynamic experiments when paired with appropriate controls.
-
Tiamulin: From Ribosome to Translational Strategy
2026-09-18
Tiamulin (Thiamutilin) is more than a veterinary pleuromutilin antibiotic. Its defined ribosomal target, exposure-response relationship in Mycoplasma gallisepticum infection, and reported effects on TNF-α-linked inflammatory signaling create a practical framework for translational researchers designing antibacterial, host-response, and formulation studies.
-
Wnt agonist 1 (BML-284) for Mechanistic Assays
2026-09-17
Wnt agonist 1 (BML-284) provides a reversible chemical route to canonical Wnt pathway activation in differentiation, developmental, and cancer-cell assays. This guide connects pathway perturbation with the Wnt/NR2F2/GPX4 chemoresistance model and translates it into practical dose design, controls, and troubleshooting.
-
Ibotenic Acid for Circuit-Level Neurobiology
2026-09-17
A translational framework for using Ibotenic acid as an NMDA receptor agonist to connect glutamatergic mechanisms, circuit phenotypes, and reproducible disease models.
-
Spatial Proteomics of PD-L1 and IL-6 in PSC
2026-09-16
A pre-proof study in JHEP Reports uses spatial proteomics and cell-cell cross-talk analysis to connect PD-L1-positive immune niches with IL-6 signaling in human primary sclerosing cholangitis. Its main contribution is a tissue-resolved framework for generating mechanistic hypotheses at the epithelial-immune interface, while also clarifying why pharmacological validation must remain distinct from spatial association.
-
Patient-Derived Prostate Spheroids as a Translational Model
2026-09-15
Linxweiler and colleagues established viable three-dimensional spheroid cultures from organ-confined prostate cancer tissue obtained during radical prostatectomy. The model preserved key epithelial and prostate cancer markers, supported cryopreservation, and revealed differential responses to androgen-receptor-directed drugs, providing a practical platform for translational prostate cancer research.
-
Direct Mouse Genotyping Kit for Reliable PCR
2026-09-15
This scenario-based guide explains how Direct Mouse Genotyping Kit K1025 can reduce handling steps and support reproducible PCR amplification from mouse tissue before cell-based experiments. It covers experimental design, storage, controls, interpretation, and practical vendor-selection criteria for routine mouse genetic screening.
-
Lipo3K Transfection Reagent for Kidney Organoids
2026-09-14
Lipo3K Transfection Reagent combines efficient plasmid, siRNA, and mRNA delivery with a low-toxicity workflow suited to kidney organoids and difficult cell models. Its Lipo3K-A enhancer supports plasmid nuclear entry, while the reagent’s flexibility enables mechanistic rescue experiments, RNA interference research, and DNA and siRNA co-transfection without routine medium exchange.
-
DAMGO for µ-Opioid Receptor Signaling Research
2026-09-14
DAMGO enables selective interrogation of µ-opioid receptor activation across receptor-proximal assays, tissue preparations, and pain-circuit studies. This workflow-focused guide connects concentration planning and storage controls with the brain-to-spinal mechanisms underlying opioid hypersensitivity and tolerance.
-
LY294002 Workflows for PI3K Signaling Studies
2026-09-13
Build reproducible PI3K/Akt/mTOR experiments with LY294002 while separating pathway-dependent effects from concentration, timing, and BET bromodomain liabilities. This practical guide connects cancer, autophagy, and doxorubicin-induced cardiac injury models to assay-ready workflows and troubleshooting decisions.
-
Capecitabine in Tumor–Stroma Assay Workflows
2026-09-12
Capecitabine enables a practical way to study enzymatically activated fluoropyrimidine activity in organoids, assembloids, and xenograft-oriented workflows. By pairing drug response with stromal composition, thymidine phosphorylase biology, and orthogonal viability or apoptosis measurements, researchers can distinguish intrinsic sensitivity from microenvironment-mediated resistance.